Taizhou-developed cancer nutrition formula wins national approval

Baituoli is a specialized total nutrition formula food for cancer patients developed by Kwins Health in Taizhou, Jiangsu. [Photo/WeChat account: tzfabu]

A specialized nutritional formula developed by Kwins Health in Taizhou, Jiangsu, has received national registration approval, marking a new achievement for the city's medical nutrition industry.

The product, named Baituoli, is a specialized total nutrition formula for cancer patients aged 10 and above. Of the four registration certificates issued nationwide so far, two belong to companies based in the China Medical City in Taizhou. The other is Oral Impact, developed by Swiss food giant Nestle.

The formulas are specifically designed to meet the nutritional needs of cancer patients. They provide a balanced supply of high-quality protein, fats, carbohydrates, vitamins, minerals and other essential nutrients. They also address the increased nutritional demands and the chronic inflammation that are often associated with cancer.

When Kwins Health launched the project in 2019, China's market for cancer-specific total nutrition formulas was still largely undeveloped. With no established national standards or mature development models to follow, the research team built its formulation from the ground up, drawing on evidence-based medical and nutritional studies. It examined the mechanisms underlying cancer-related malnutrition and systematically tested various nutrient combinations to determine the final formula.

Kwins Health has now secured 14 registration certificates for foods for special medical purposes (FSMP). The company has also established automated production lines for powder, emulsion and liquid products.

Since the beginning of this year, six new FSMP registration certificates have been granted to companies in China Medical City, bringing the park's total to 27. Both the number of companies and the number of registered products rank first in Jiangsu province.